Brainsway公司近日披露，信诺保险（Cigna）旗下的Evernorth行为健康部门将取消经颅磁刺激（TMS）疗法承保的事前授权要求。这一政策变革预计将显著简化治疗流程，使患者能够更快速地获得针对抑郁症等精神健康问题的创新治疗方案。医疗服务的可及性由此得到实质性提升，为亟需精神健康干预的人群扫除了行政障碍。此举不仅体现了医疗支付方对非药物疗法的支持升级，也可能进一步推动TMS技术在临床中的普及应用。
Brainsway公司近日披露，信诺保险（Cigna）旗下的Evernorth行为健康部门将取消经颅磁刺激（TMS）疗法承保的事前授权要求。这一政策变革预计将显著简化治疗流程，使患者能够更快速地获得针对抑郁症等精神健康问题的创新治疗方案。医疗服务的可及性由此得到实质性提升，为亟需精神健康干预的人群扫除了行政障碍。此举不仅体现了医疗支付方对非药物疗法的支持升级，也可能进一步推动TMS技术在临床中的普及应用。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.